植物の生長調節
Online ISSN : 2189-6305
Print ISSN : 1346-5406
談話室
スギ花粉米の最近の研究開発状況
髙野 誠
著者情報
ジャーナル 認証あり

2019 年 54 巻 1 号 p. 82-86

詳細
抄録

We have developed the vaccine rice for cedar pollen allergy and have been trying to commercialize it since then. At first, we aimed to commercialize it as food for specified health use, but the Ministry of Health, Labour and Welfare had a different opinion. Then, we had made efforts to bring it out as the medicine by consulting with Pharmaceuticals and Medical Devices Agency (PMDA). However, any pharmaceutical companies embarked on this challenging project. Now, we are trying to accumulate the evidence in clinical studies in collaboration with medical institutions. Hopefully, a new functional food category between medicine and food will be established in near future and the vaccine rice will be approved as a functional food by receiving a big boost from patients suffer from pollinosis.

著者関連情報
© 2019 一般社団法人植物化学調節学会
前の記事 次の記事
feedback
Top